Brightlands Venture Partners | Activity | F4

F4/Brightlands Venture Partners/Activity

Brightlands Venture Partners Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

4 investments· SEP 2026Show all

Investment

Matisse Pharmaceuticals closed a Series A financing round to advance isupartob sodium through phase 2 clinical development.

Matisse Pharmaceuticals

Matisse Pharmaceuticals Brightlands Venture Partners

bvp.capitalSEP 17, 2026

SEP 17, 2026

Investment

Greencovery raised €1M to scale its cocoa upcycling technology, targeting a €3M follow-on round.

Greencovery

Greencovery Brightlands Venture Partners

bvp.capitalSEP 14, 2026

SEP 14, 2026

Investment

Gravity Gardens raised €2.6 million for its dry, chemical-free seed activation technology.

Gravity Gardens

Gravity Gardens Brightlands Venture Partners

bvp.capitalSEP 9, 2026

SEP 9, 2026

Investment

BVP and Bio&Tech Smart Capital joined Healthplus.ai's seed extension to bring AI infection-risk prediction to surgical teams.

Healthplus.ai

Healthplus.ai Brightlands Venture Partners

bvp.capitalSEP 3, 2026

SEP 3, 2026

Milestone

Portfolio company Vivalyx's Omnisol® was granted Breakthrough Medical Devices Status by the European Medicines Agency.

Vivalyx

Vivalyx Brightlands Venture Partners

bvp.capitalAUG 27, 2026

AUG 27, 2026

Investment

Silicozyme emerged from stealth, backed by BVP and LIOF, to make protein production simpler, lower-cost, and more scalable.

Silicozyme

Silicozyme Brightlands Venture Partners

bvp.capitalJUL 16, 2026

JUL 16, 2026

Exit

SHS Capital acquired a majority stake in portfolio company Basic Pharma.

Basic Pharma

Basic Pharma Brightlands Venture Partners

bvp.capitalJUL 14, 2026

JUL 14, 2026

Essay

Published its 2025 Impact Report on translating early-stage innovation into system-level change.

From early stage innovation to system level change: our 2025 Impact Report

Brightlands Venture Partners

bvp.capitalJUN 30, 2026

JUN 30, 2026

Milestone

Portfolio company Grassa won the Transition Award 2026 in the Food category.

Grassa

Grassa Brightlands Venture Partners

bvp.capitalJUN 24, 2026

JUN 24, 2026

Milestone

Portfolio company Vivalyx won the Purpose and Impact Award at the ODDO BHF Young Entrepreneurs Awards 2026.

Vivalyx

Vivalyx Brightlands Venture Partners

bvp.capitalJUN 19, 2026

JUN 19, 2026

Investment

Vertoro closed a €17M Series B round to advance its renewable oil platform and accelerate low-carbon fuels.

Vertoro

Vertoro Brightlands Venture Partners

bvp.capitalJUN 17, 2026

JUN 17, 2026

3 milestones· JUN 2026Show all

Milestone

Honda began using portfolio company Circularise to strengthen battery passport readiness ahead of 2027 EU requirements.

Circularise

Circularise Brightlands Venture Partners

bvp.capitalJUN 10, 2026

JUN 10, 2026

Milestone

Matisse Pharmaceuticals received FDA Fast Track Designation for isupartob sodium in sepsis.

Matisse Pharmaceuticals

Matisse Pharmaceuticals Brightlands Venture Partners

bvp.capitalJUN 9, 2026

JUN 9, 2026

Milestone

Portfolio company Hy2Care was selected for the MedTech Innovator 2026 Accelerator Cohort.

Hy2Care

Hy2Care Brightlands Venture Partners

bvp.capitalJUN 2, 2026

JUN 2, 2026

Page 1 of 2